Health
First Ebola Vaccine Trial Launched in DR Congo
BBC · 3 hours ago · Read the Full Story on BBC
AI SUMMARY
The World Health Organization announced the start of clinical trials for an Ebola vaccine in the Democratic Republic of Congo to combat the country's largest Bundibugyo ebolavirus outbreak.
- The World Health Organization announced the commencement of clinical trials for an Ebola vaccine in the Democratic Republic of Congo.
- The first participants in Bunia, the capital of Ituri province, received the 'Ervebo' vaccine on Friday.
- The trial, named 'Tumaini' which means 'hope' in Swahili, evaluates protection against the Bundibugyo ebolavirus for which no approved vaccine currently exists.
- Health authorities report 9,704 infections and 4,687 deaths in the country's largest and deadliest Bundibugyo ebolavirus outbreak.
- Future trial phases are expected to include vaccines developed by Moderna and the University of Oxford.
- The study focuses on vaccinating individuals who have had contact with confirmed Ebola cases and face a high risk of infection.
- The trial is co-led by the DRC's National Institute of Biomedical Research and the University of Antwerp with support from multiple international and national partners.
Related
Second Ebola Death Reported in Kenya
BBC · 9 hours ago
Three Services Transferred from Addis Ababa FDA to Health Bureau
Wazema · 23 hours ago
Nigeria's Health Minister Says First Ebola Case Remains Isolated
Africa News · yesterday
Ebola: Africa CDC Calls Crisis Meeting as Virus Spreads
Deutsche Welle · yesterday